615 related articles for article (PubMed ID: 12620436)
1. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
[TBL] [Abstract][Full Text] [Related]
2. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
4. Effect of postmenopausal estrogen replacement on circulating androgens.
Casson PR; Elkind-Hirsch KE; Buster JE; Hornsby PJ; Carson SA; Snabes MC
Obstet Gynecol; 1997 Dec; 90(6):995-8. PubMed ID: 9397118
[TBL] [Abstract][Full Text] [Related]
5. Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women.
Stanczyk FZ; Chaikittisilpa S; Sriprasert I; Rafatnia A; Nadadur M; Mishell DR
Climacteric; 2019 Apr; 22(2):169-174. PubMed ID: 30612472
[TBL] [Abstract][Full Text] [Related]
6. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
7. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
Lukanova A; Lundin E; Zeleniuch-Jacquotte A; Muti P; Mure A; Rinaldi S; Dossus L; Micheli A; Arslan A; Lenner P; Shore RE; Krogh V; Koenig KL; Riboli E; Berrino F; Hallmans G; Stattin P; Toniolo P; Kaaks R
Eur J Endocrinol; 2004 Feb; 150(2):161-71. PubMed ID: 14763914
[TBL] [Abstract][Full Text] [Related]
8. Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients.
Geisler J; Haynes B; Anker G; Helle H; Ekse D; Dowsett M; Lønning PE
J Steroid Biochem Mol Biol; 2005 Sep; 96(5):415-22. PubMed ID: 16168635
[TBL] [Abstract][Full Text] [Related]
9. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
Stomati M; Hartmann B; Spinetti A; Mailand D; Rubino S; Albrecht A; Huber J; Petraglia F; Genazzani AR
J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
[TBL] [Abstract][Full Text] [Related]
10. Serum estrogens and androgens in women with endometrial carcinoma.
Pettersson B; Bergström R; Johansson ED
Gynecol Oncol; 1986 Oct; 25(2):223-33. PubMed ID: 2944804
[TBL] [Abstract][Full Text] [Related]
11. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
Genazzani AD; Stomati M; Bernardi F; Pieri M; Rovati L; Genazzani AR
Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
[TBL] [Abstract][Full Text] [Related]
12. Sex hormones in postmenopausal women receiving low-dose hormone therapy: the effect of BMI.
Lambrinoudaki I; Armeni E; Rizos D; Deligeoroglou E; Kofinakos P; Kaparos G; Alexandrou A; Creatsa M; Logothetis E; Kouskouni E
Obesity (Silver Spring); 2011 May; 19(5):988-93. PubMed ID: 20948523
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
Adly L; Hill D; Sherman ME; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Schairer C
Int J Cancer; 2006 Nov; 119(10):2402-7. PubMed ID: 16894564
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.
Harrington LB; Marck BT; Wiggins KL; McKnight B; Heckbert SR; Woods NF; LaCroix AZ; Blondon M; Psaty BM; Rosendaal FR; Matsumoto AM; Smith NL
J Thromb Haemost; 2017 Jan; 15(1):80-90. PubMed ID: 27797446
[TBL] [Abstract][Full Text] [Related]
15. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.
Edlefsen KL; Jackson RD; Prentice RL; Janssen I; Rajkovic A; O'Sullivan MJ; Anderson G
Menopause; 2010; 17(3):622-9. PubMed ID: 20215977
[TBL] [Abstract][Full Text] [Related]
16. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
Morales AJ; Haubrich RH; Hwang JY; Asakura H; Yen SS
Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
[TBL] [Abstract][Full Text] [Related]
17. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female.
Ali I; James T; Meston N; Wojnarowska F; Shine B
Clin Chem Lab Med; 2009; 47(2):202-7. PubMed ID: 19191727
[TBL] [Abstract][Full Text] [Related]
18. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.
Jankowski CM; Gozansky WS; Kittelson JM; Van Pelt RE; Schwartz RS; Kohrt WM
J Clin Endocrinol Metab; 2008 Dec; 93(12):4767-73. PubMed ID: 18812486
[TBL] [Abstract][Full Text] [Related]
19. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
20. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
Stomati M; Rubino S; Spinetti A; Parrini D; Luisi S; Casarosa E; Petraglia F; Genazzani AR
Gynecol Endocrinol; 1999 Feb; 13(1):15-25. PubMed ID: 10368794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]